Financials
Financial year 2025
PHARMACIE GANSER from Villers-le-Bouillet, company number BE0878672817, closed financial year 2025 with a result of € 43,874 after tax. For that financial year PHARMACIE GANSER recorded a gross margin of € 366,407 and equity of € 316,557. Compared with financial year 2024, the result moved from € 95,281 to € 43,874. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 316,557
▼ 33% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 43,874
▼ 54% vs 2024
Profit after tax over the fiscal year.
€ 110,430
▼ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 202,220 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
3.1
▼ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 229,691
▼ 3% vs 2024
€ 74,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 12,285
▼ 55% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 119,611
▼ 32% vs 2024
€ 50,763 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 153,116
▼ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 27,281
▼ 19% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 346,882 | € 354,343 | € 439,083 | € 366,407 | ▼ 17% |
| Profit after taxes | € 79,387 | € 68,173 | € 95,281 | € 43,874 | ▼ 54% |
| Equity | € 332,164 | € 379,623 | € 474,903 | € 316,557 | ▼ 33% |
| Total debts | € 531,631 | € 462,024 | € 387,466 | € 300,031 | ▼ 23% |
| Cash | € 233,737 | € 197,868 | € 224,121 | € 110,430 | ▼ 51% |
| Retained profit | € 307,164 | € 354,623 | € 449,903 | € 291,557 | ▼ 35% |
| Dividend | € 4,789 | € 20,714 | € 0 | € 202,220 | |
| Bank debt | € 283,029 | € 231,067 | € 174,912 | € 119,611 | ▼ 32% |
| Balance sheet total | € 863,795 | € 841,646 | € 862,369 | € 616,588 | ▼ 29% |
| Employees (FTE) | 2.8 | 3 | 3.9 | 3.1 | ▼ 0.8 |
Key figures of PHARMACIE GANSER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE GANSER?
What happened at PHARMACIE GANSER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 43,874 (▼ 54% vs 2024). Source: NBB ↗
- PHARMACIE LEJEUNE became a director. NBB
- New establishment in Plombières. KBO
- Start of the company according to the CBE. KBO
In short
From € 79,387 profit in 2022 to € 43,874 profit in 2025.
Paid € 98,674 in corporate taxes since 2022.
Best year ever: 2024, with € 95,281 profit.
On average € 118,200 of value added per employee in 2025.
A new publication or filing at PHARMACIE GANSER? We notify you, reason included.
Follow PHARMACIE GANSERDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE GANSER is PHARMACIE LEJEUNE. PHARMACIE LEJEUNE is also behind PHARMACIE BEAUMONT, Pharmacie J.P. Detry - Discry, PHARMACIE DES FORGES, PHARMACIE DE DONCEEL and PHARMACIE DUBOIS-HUSSON.
Directors
According to the 2025 annual accounts
Représentant permanent · represented by François-Xavier OLIVIER
Also active at: PHARMACIE BEAUMONT, Pharmacie J.P. Detry - Discry, PHARMACIE DES FORGES, PHARMACIE DE DONCEEL, PHARMACIE DUBOIS-HUSSON, Pharmacie DETRY-DUPONT, PHARMACIE R. WALNIER, Pharmacie BILLEN +10 more
since 2026
Establishments
Establishment units
Physical locations of this company
Rue de l'Entreprise 12
4530 Villers-le-Bouillet
Rue César Franck 60
4851 Plombières
Active since 26 January 2006
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0878.672.817
- VAT number
- BE 0878.672.817
- Registered office
- Rue de l'Entreprise 12, 4530 Villers-le-Bouillet
- Names & denominations
- PHARMACIE GANSER
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 2006
- Peppol
- Active · Active since 12 Jan 2026
- Activities · NACE
Apothekers
Apotheken
Detailhandel in medische en orthopedische artikelen
Vervaardiging van geneesmiddelen
Vervaardiging van overige farmaceutische preparaten
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.
Vervaardiging van farmaceutische grondstoffen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
+4